Mitchell L. Shiffman
- Hepatology top 0.01%
- Hepatitis C virus research 193
- Liver Disease and Transplantation 63
- Liver Diseases and Immunity 24
- Epidemiology top 0.01%
- Liver Disease Diagnosis and Treatment 196
- Hepatitis B Virus Studies 119
- Rheumatology top 0.2%
- Systemic Lupus Erythematosus Research 24
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment 15
-
- Organ Transplantation Techniques and Outcomes 15
- Co-authors
- Janice K. AlbrechtStuart C. GordonJohn G. McHutchisonVinod K. RustgiZachary GoodmanArun J. SanyalVelimir A. LuketicRichard K. Sterling
- Cited by
- HepatologyEpidemiologyRheumatology
- Journals
- Hepatology (54 papers)Gastroenterology (37 papers)The American Journal of Gastroenterology (18 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Mitchell L. Shiffman
272 papers receiving 33.2k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Hepatology 27.9k
- Epidemiology 27.7k
- Rheumatology 2.4k
- Infectious Diseases 2.8k
- Endocrinology, Diabetes and Metabolism 2.4k
Countries citing papers authored by Mitchell L. Shiffman
This map shows the geographic impact of Mitchell L. Shiffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell L. Shiffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell L. Shiffman more than expected).
Fields of papers citing papers by Mitchell L. Shiffman
This network shows the impact of papers produced by Mitchell L. Shiffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell L. Shiffman. The network helps show where Mitchell L. Shiffman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mitchell L. Shiffman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2021 | 24 | |
| 3 | Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non‐alcoholic fatty liver disease | 2019 | 0 |
| 4 | 2019 | 34 | |
| 5 | The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC. | 2019 | 3 |
| 6 | 2013 | 98 | |
| 7 | 2012 | 3 | |
| 8 | 2012 | 79 | |
| 9 | 2010 | 89 | |
| 10 | 2009 | 30 | |
| 11 | Double blind, randomized, placebo-controlled, multi-center,phase II dose ranging study to assess the antifibrotic activityof farglitazar in chronic hepatitis C infection. | 2008 | 2 |
| 12 | 2008 | 22 | |
| 13 | 2008 | 13 | |
| 14 | 2007 | 98 | |
| 15 | 2007 | 13 | |
| 16 | 2004 | 64 | |
| 17 | 2004 | 116 | |
| 18 | 2004 | 47 | |
| 19 | Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis Cbreakdown → | 1998 | 1070 |
| 20 | 1996 | 88 |
About Mitchell L. Shiffman
Mitchell L. Shiffman is a scholar working on Hepatology, Epidemiology and Rheumatology, having authored 275 papers that have together received 34.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (196 papers), Hepatitis C virus research (193 papers), Hepatitis B Virus Studies (119 papers), Liver Disease and Transplantation (63 papers), Liver Diseases and Immunity (24 papers), Systemic Lupus Erythematosus Research (24 papers), Organ Transplantation Techniques and Outcomes (15 papers) and HIV/AIDS drug development and treatment (15 papers). The work is most often cited by research in Hepatology (27.9k citations), Epidemiology (27.7k citations) and Rheumatology (2.4k citations). Mitchell L. Shiffman has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Janice K. Albrecht, Stuart C. Gordon, John G. McHutchison, Vinod K. Rustgi, Zachary Goodman, Arun J. Sanyal, Velimir A. Luketic, Richard K. Sterling, Robert Reindollar and K. Rajender Reddy. Their work appears in journals such as Hepatology, Gastroenterology, The American Journal of Gastroenterology, Journal of Hepatology and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.